Libero Pharma LIMITED
Scotland
- UEI
- KDK7WQD2CZQ7
- CAGE
- U1R72
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- International Organization
- SAM.gov registration date
- Physical address
- 38 Thistle St, Edinburgh EH2 1EN, UK
- Website
- liberopharma.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Naltrexone transdermal patch - an accessible, patient-focused option to treat OUD relapse - the U.S. Remains firmly… | National Institute on Drug Abuse (NIH) | $12,702,030 |
Quick answers
Is Libero Pharma LIMITED registered in SAM.gov?
Yes. Libero Pharma LIMITED's SAM.gov registration is active through June 10, 2027.
What is Libero Pharma LIMITED's most recent federal award?
Libero Pharma LIMITED's most recent federal grant award is Naltrexone transdermal patch - an accessible, patient-focused option to treat OUD relapse - the U.S. Remains firmly… (UG3DA057853), from National Institute on Drug Abuse (NIH), on September 30, 2022.
On GovTribe
See Libero Pharma LIMITED's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors